Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO study" in JU ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal ...

Blue light cystoscopy had a statistically significant reduction in risk of recurrence versus white light cystoscopy in high-risk bladder cancer.

BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...

Conducted in 17 UK hospitals, the study involved 143 patients, comparing mpMRI and TURBT pathways for staging bladder cancer. The mpMRI pathway allowed for faster treatment initiation, with a median ...

Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several ...

Gene's lead asset shows high complete response rates in BCG-unresponsive NMIBC patients. Click here to read why ENGN stock is a Buy.

An artificial intelligence platform may help identify BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC) and steer alternative treatment.

open-label clinical study designed to assess the safety and feasibility of local administration of bel-sar as a monotherapy prior to transurethral resection of bladder tumor (TURBT), the standard ...

Dr. Rohan Patel, senior uro-oncologist and robotic surgeon in Ahmedabad, successfully performs rare robotic surgery on a ...

TURP/TURBT, PCNL/RIRS, kidney stone surgery, laparoscopic urology, diagnostic flexible cystoscopy, lipoma removal, circumcisions, and hernia repairs. The Sakinah Medical Outreach has provided free ...